DK0763036T3 - [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien - Google Patents
[a]-Annelerede pyrrolderivater og deres anvendelse i farmacienInfo
- Publication number
- DK0763036T3 DK0763036T3 DK95921799T DK95921799T DK0763036T3 DK 0763036 T3 DK0763036 T3 DK 0763036T3 DK 95921799 T DK95921799 T DK 95921799T DK 95921799 T DK95921799 T DK 95921799T DK 0763036 T3 DK0763036 T3 DK 0763036T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- assolved
- pharmacy
- pyrrole derivatives
- sec
- Prior art date
Links
- 150000003233 pyrroles Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4419246A DE4419246A1 (de) | 1994-06-01 | 1994-06-01 | Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie |
PCT/EP1995/002077 WO1995032970A1 (de) | 1994-06-01 | 1995-05-31 | [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0763036T3 true DK0763036T3 (da) | 2002-12-02 |
Family
ID=6519584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95921799T DK0763036T3 (da) | 1994-06-01 | 1995-05-31 | [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien |
Country Status (14)
Country | Link |
---|---|
US (1) | US5958943A (es) |
EP (1) | EP0763036B1 (es) |
JP (1) | JP3671302B2 (es) |
KR (1) | KR100378883B1 (es) |
AT (1) | ATE223917T1 (es) |
AU (1) | AU2672895A (es) |
CA (1) | CA2191747C (es) |
DE (2) | DE4419246A1 (es) |
DK (1) | DK0763036T3 (es) |
ES (1) | ES2182903T3 (es) |
FI (1) | FI113964B (es) |
NO (1) | NO310291B1 (es) |
PT (1) | PT763036E (es) |
WO (1) | WO1995032970A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59908677D1 (de) * | 1999-11-23 | 2004-04-01 | Merckle Gmbh | Antiinflammatorische oxo- und hydroxyderivate von pyrrolizinen und deren anwendung in der pharmazie |
DE10001166A1 (de) * | 2000-01-13 | 2001-07-19 | Merckle Gmbh | Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung |
PL208027B1 (pl) * | 2000-01-28 | 2011-03-31 | Merckle Gmbh | Sposób wytwarzania kwasu 6-(4-chlorofenylo)-2,2-dimetylo-7-fenylo-2,3-dihydro-1H-pirolizyn-5-yloctowego, związek pośredni, kwas 6-(4-chlorofenylo)-2, 2-dimetylo-7-fenylo-2, 3-dihydro-1H-pirolizyn-5-yloctowy, środek farmaceutyczny i zastosowanie tego kwasu |
DE10004157A1 (de) * | 2000-02-01 | 2001-08-02 | Merckle Gmbh Chem Pharm Fabrik | 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie |
DE10141285A1 (de) | 2001-08-23 | 2003-03-27 | Merckle Gmbh | Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure |
US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
EP1505964B1 (en) * | 2002-05-17 | 2007-11-21 | Merckle Gmbh | Annelated pyrrole compounds as proton pump inhibitors for treating ulcer |
PL376056A1 (en) * | 2002-09-27 | 2005-12-12 | Janssen Pharmaceutica N.V. | 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases |
CN101792417A (zh) * | 2003-06-17 | 2010-08-04 | 艾尼纳制药公司 | 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物 |
SI2332921T1 (sl) * | 2003-06-17 | 2016-06-30 | Arena Pharmaceuticals, Inc. | 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid |
WO2005042490A1 (en) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
WO2005042491A1 (en) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
ES2332009T3 (es) | 2004-12-21 | 2010-01-22 | Arena Pharmaceuticals, Inc. | Formas cristalinas de hidrocloruro de (r)-8-cloro-1-metil-2,3,4,5-tetrahidro-1h-3-benzazepina. |
SI1833473T1 (sl) * | 2004-12-23 | 2010-01-29 | Arena Pharm Inc | Sestavki modulatorjev 5HT2C receptorjev in postopki uporabe |
DE102005012971A1 (de) | 2005-03-21 | 2006-09-28 | Merckle Gmbh | Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure |
CA2646044A1 (en) * | 2006-04-03 | 2007-10-25 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto |
SG177128A1 (en) * | 2006-12-05 | 2012-01-30 | Arena Pharm Inc | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
JP5491421B2 (ja) * | 2008-03-04 | 2014-05-14 | アリーナ ファーマシューティカルズ, インコーポレイテッド | 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス |
EP2443080A2 (en) | 2009-06-18 | 2012-04-25 | Arena Pharmaceuticals, Inc. | Process for the preparation of 5-ht2c receptor agonists |
KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ht2c 수용체 아고니스트의 제조 방법 |
SG188365A1 (en) | 2010-09-01 | 2013-04-30 | Arena Pharm Inc | Administration of lorcaserin to individuals with renal impairment |
MX2013002422A (es) | 2010-09-01 | 2013-05-17 | Arena Pharm Inc | Sales de lorcaserina con acidos opticamente activos. |
EP3485878A1 (en) | 2010-09-01 | 2019-05-22 | Arena Pharmaceuticals, Inc. | Modified-release dosage forms of 5-ht2c agonists useful for weight management |
CN103189360A (zh) | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | 5-ht2c激动剂的非吸湿性盐 |
AU2012392187B2 (en) | 2012-10-09 | 2018-07-12 | Arena Pharmaceuticals, Inc. | Method of weight management |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1461592A (en) * | 1973-04-25 | 1977-01-13 | Agfa Gevaert | Specially sensitized direct positive silver halide emulsions |
US3920672A (en) * | 1974-08-22 | 1975-11-18 | Syntex Inc | Thiacycl (2.2.2.)azine carboxylic acids |
US4536512A (en) * | 1982-10-08 | 1985-08-20 | Merck & Co., Inc. | 5-(2,3-Dihydro-1H-pyrrolizin-5-oyl)-2,3-dihydro-1H-pyrrolizine-1-alkanoic or carboxylic acids and use thereof as anti-inflammatory and analgesic agents |
FR2539417A1 (fr) * | 1983-01-13 | 1984-07-20 | Rhone Poulenc Sante | Nouveaux pyrrolo-1, 2 heterocycles, leur preparation et les medicaments qui les contiennent |
AU562833B2 (en) * | 1983-01-13 | 1987-06-18 | Rhone-Poulenc Sante | Ortho-fused pyrrole derivatives |
FR2557111B1 (fr) * | 1983-12-21 | 1986-04-11 | Rhone Poulenc Sante | Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent |
US5260451A (en) * | 1989-05-11 | 1993-11-09 | Merckle Gmbh | Substituted pyrrole compounds and use thereof in pharmaceutical compositions |
DE3915450A1 (de) * | 1989-05-11 | 1990-11-15 | Gerd Prof Dr Dannhardt | Substituierte pyrrolverbindungen und deren anwendung in der pharmazie |
JPH05289267A (ja) * | 1992-04-07 | 1993-11-05 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー写真感光材料 |
US5552422A (en) * | 1995-01-11 | 1996-09-03 | Merck Frosst Canada, Inc. | Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
-
1994
- 1994-06-01 DE DE4419246A patent/DE4419246A1/de not_active Ceased
-
1995
- 1995-05-31 JP JP50033296A patent/JP3671302B2/ja not_active Expired - Fee Related
- 1995-05-31 WO PCT/EP1995/002077 patent/WO1995032970A1/de active IP Right Grant
- 1995-05-31 ES ES95921799T patent/ES2182903T3/es not_active Expired - Lifetime
- 1995-05-31 KR KR1019960706836A patent/KR100378883B1/ko not_active IP Right Cessation
- 1995-05-31 CA CA002191747A patent/CA2191747C/en not_active Expired - Fee Related
- 1995-05-31 DE DE59510370T patent/DE59510370D1/de not_active Expired - Fee Related
- 1995-05-31 AT AT95921799T patent/ATE223917T1/de not_active IP Right Cessation
- 1995-05-31 DK DK95921799T patent/DK0763036T3/da active
- 1995-05-31 PT PT95921799T patent/PT763036E/pt unknown
- 1995-05-31 AU AU26728/95A patent/AU2672895A/en not_active Abandoned
- 1995-05-31 US US08/737,919 patent/US5958943A/en not_active Expired - Fee Related
- 1995-05-31 EP EP95921799A patent/EP0763036B1/de not_active Expired - Lifetime
-
1996
- 1996-11-29 FI FI964771A patent/FI113964B/fi active
- 1996-11-29 NO NO19965093A patent/NO310291B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
JPH10506368A (ja) | 1998-06-23 |
ES2182903T3 (es) | 2003-03-16 |
NO310291B1 (no) | 2001-06-18 |
KR100378883B1 (ko) | 2003-08-02 |
EP0763036B1 (de) | 2002-09-11 |
ATE223917T1 (de) | 2002-09-15 |
EP0763036A1 (de) | 1997-03-19 |
DE4419246A1 (de) | 1995-12-07 |
WO1995032970A1 (de) | 1995-12-07 |
JP3671302B2 (ja) | 2005-07-13 |
DE59510370D1 (de) | 2002-10-17 |
AU2672895A (en) | 1995-12-21 |
CA2191747C (en) | 2007-01-23 |
FI964771A (fi) | 1997-01-27 |
FI964771A0 (fi) | 1996-11-29 |
FI113964B (fi) | 2004-07-15 |
NO965093L (no) | 1996-11-29 |
US5958943A (en) | 1999-09-28 |
CA2191747A1 (en) | 1995-12-07 |
NO965093D0 (no) | 1996-11-29 |
PT763036E (pt) | 2002-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0763037T3 (da) | [a]-Annellerede pyrrolderivater og deres anvendelse i farmacien | |
DK0763036T3 (da) | [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien | |
DK0804437T3 (da) | [a]-Annelerede pyrrolderivater og deres anvendelse i farmacien | |
NO952132L (no) | Farmakologiske aktive pyridin-derivater og deres fremstilling | |
BR9205811A (pt) | Derivados heterociclicos de aminas ciclicas | |
NO306346B1 (no) | N-substituerte azabicykloalkanderivater, anvendelse derav og farmasöytisk preparat | |
NO20003233D0 (no) | 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler | |
DK0888353T3 (da) | N-7-Heterocyclyl-pyrrolo[2,3-d]pyrimidiner og deres anvendelse | |
NO304889B1 (no) | Imidazopyridiner og deres anvendelse ved fremstilling av legemidler til behandling av mave-tarm-sykdommer | |
NO952309D0 (no) | Anvendelse av riluzol ved behandling av Parkinsons sykdom og Parkinsonske syndromer | |
DE59409735D1 (de) | ALKOXYALKYLCARBAMATE VON IMIDAZO[1,2-a]PYRIDINEN | |
NO306400B1 (no) | N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat | |
DK0707477T3 (da) | Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo | |
CA2191746A1 (en) | [a]-annelated pyrrole derivatives and pharmaceutical use thereof | |
DK1105388T3 (da) | N-substituerede azabicycloheptan-derivater, fremstilling og anvendelse heraf |